Market revenue in 2021 | USD 1,049.6 million |
Market revenue in 2028 | USD 1,056.5 million |
Growth rate | 0.1% (CAGR from 2021 to 2028) |
Largest segment | Pcr-based amplification |
Fastest growing segment | Loop Mediated Isothermal Amplification (LAMP) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | PCR-based Amplification, Loop Mediated Isothermal Amplification (LAMP), Nucleic Acid Sequence Based Amplification (NASBA), Strand Displacement Amplification (SDA), Multiple displacement amplification (MDA), Rolling Circle Amplification (RCA), Ramification amplification method (RAM) |
Key market players worldwide | Qiagen NV, Illumina Inc, Bio-Rad Laboratories Inc, Silicon Laboratories Inc, Merck KGaA, Promega, Takara Bio Inc, Danaher Corp, New England Biolabs, 4Basebio, LGC Group, Vazyme Biotech, MyBiosource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to gene amplification technologies market will help companies and investors design strategic landscapes.
Pcr-based amplification was the largest segment with a revenue share of 90.63% in 2021. Horizon Databook has segmented the India gene amplification technologies market based on pcr-based amplification, loop mediated isothermal amplification (lamp), nucleic acid sequence based amplification (nasba), strand displacement amplification (sda), multiple displacement amplification (mda), rolling circle amplification (rca), ramification amplification method (ram) covering the revenue growth of each sub-segment from 2018 to 2028.
India is anticipated to witness healthy growth in the adoption and development of gene amplification technologies owing to changing market demands in the country. In October 2019, the Indian Institute of Science and Christian Medical College presented a novel, inexpensive, rapid, and POC compatible nucleic acid amplification tests for the detection of Tuberculosis in limited-resource settings.
This device enabled filter-free fluorescence detection of amplified DNA. Moreover, serological screening is mandatory in India. To avoid the risk of transfusion-transmitted infections Nucleic Acid Amplification Testing (NAT) can be done.
In October 2019, Indian researchers published a research study for the analysis of nucleic acid amplification screening by using Indian manufactured Individual Donor NAT. Such active engagement of the country's research community is anticipated to positively impact market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the India gene amplification technologies market , including forecasts for subscribers. This country databook contains high-level insights into India gene amplification technologies market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account